Technical Intelligence & Insights
Explore our curated collection of technical analyses and commercial scale-up strategies specifically focused on Peptide. These insights are designed to support R&D and procurement teams in optimizing their supply chains.
Patent CN108484735A details solid-phase synthesis of cyclic heptapeptides. Offers high purity, scalable production, and cost-effective marine drug intermediate manufacturing solutions.
Patent CN103665109B reveals liquid phase synthesis for OGP pentapeptide. Offers cost reduction and scalability for pharmaceutical manufacturing supply chains.
Patent CN118791551B details high-purity semaglutide dipeptide fragment synthesis. Offers cost reduction and supply chain reliability for pharmaceutical intermediates globally.
Patent CN103554226B details all-solid-phase synthesis for alpha-conotoxin MI. Enhances purity and supply chain reliability for pharmaceutical intermediate manufacturing.
Novel solid-phase method improves purity and yield significantly. Reduces impurities and production costs for scalable manufacturing of cardiovascular drugs.
Patent CN117659159A details a novel solution-phase synthesis for Semaglutide side chains, offering significant cost reduction and supply chain reliability for global buyers.
Patent CN101712716B details a solid-phase iodine oxidation method for Vapreotide, improving yield and purity while simplifying manufacturing for reliable supply chains.
Patent CN104311639A details improved solid-phase synthesis for Somatostatin. Enhances purity and yield while reducing oxidation risks for supply chain stability.
Patent CN102816211B details a high-yield Fmoc solid-phase synthesis for Afamelanotide, offering safer production and cost reduction in pharmaceutical manufacturing.
Patent CN101284862B reveals a novel L-carnosine synthesis route achieving >99.5% purity. Discover cost-effective manufacturing and scalable supply chain solutions.
Patent CN117964681B offers novel TiO2 method reducing TFA. Enhances supply chain reliability and purity for pharmaceutical intermediates.
Patent CN116283627A offers efficient synthesis of Melphalan Impurity G. This method reduces production complexity and improves supply chain reliability for global API manufacturers seeking high purity standards.
Novel enzymatic route for high-purity peptide intermediates. Reduces cost and improves scalability for pharmaceutical manufacturing processes globally.
Patent CN105646675B details efficient solid-phase synthesis of Coibamide A analogues. Enhances yield and purity for reliable pharmaceutical intermediate supply chains.
Patent CN118955625A reveals segmented synthesis for HER2 targeting peptide. Enhances purity and yield for scalable pharmaceutical intermediates manufacturing.
Patent CN1331883C reveals an efficient synthesis of perindopril intermediates using natural amino acids, offering significant cost reduction and supply chain stability for pharmaceutical manufacturers.
Patent CN106518963A reveals solid-phase synthesis for Auristatin derivatives. Reduces impurities and enhances supply chain reliability for ADC intermediates.
Patent CN101693738B reveals a green solid-phase oxidation method for Terlipressin, offering higher yields and reduced waste for reliable API manufacturing.
Novel fragment method for linaclotide preparation ensures high purity and scalable production for global supply chains.
Novel patent CN113173987B enables high-purity lixisenatide production with reduced purification complexity and enhanced supply chain reliability for global pharmaceutical partners.